Summary:
Click image to enlargeRandomized, Double-Blind, Placebo-Contrlled Study to Assess the Effect of Bempedoic Acid (ETC-1002) on the Occurance of Major Cardiovascular Events in patients with, or at High Risk for, Cardiovascular Disease who are Statin Intolerant.
Qualified Participants Must:
• Have High Cholesterol
•
Be at least 18 years old
• Have a history of, or are at High Risk for Cardiovascular Disease
•
Are Statin Intolerant
Qualified Participants May Receive:
All study-related medication and assessments will be provided at no cost
Travel Reimbursement